Genetic factors associated with tuberculosis-related clinical outcomes in HIV-infected Black African patients: a systematic review and meta-analysis.
Innocent Gerald AsiimweDaniel KiizaStephen Ian WalimbwaChristine Wiltshire SekaggyaPublished in: Pharmacogenomics (2021)
Aim: To evaluate the genetic factors influencing tuberculosis (TB) clinical outcomes in HIV-infected Black African patients. Materials & methods: We systematically searched and identified eligible publications from >550 databases indexed through February 2021. Results: Eighteen studies were included in the qualitative synthesis. Only two cohorts from one study were included in quantitative synthesis of which the low expression MIF-794 CATT5,6 (5/5 + 5/6 + 6/6) genotypes were not associated with TB infectivity in HIV-infected patients (OR: 1.31, 95% CI: 0.46-3.79). Other TB clinical outcomes observed in HIV/TB co-infected patients included: drug-induced liver injury, peripheral neuropathy, mortality, lung function and TB cure. Conclusion: This review finds inconclusive evidence that genetic factors are associated with TB clinical outcomes among HIV-infected patients in sub-Saharan Africa.
Keyphrases
- antiretroviral therapy
- hiv infected
- hiv infected patients
- mycobacterium tuberculosis
- end stage renal disease
- hiv aids
- lung function
- hiv positive
- human immunodeficiency virus
- chronic kidney disease
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- genome wide
- prognostic factors
- chronic obstructive pulmonary disease
- emergency department
- air pollution
- pulmonary tuberculosis
- hepatitis c virus
- cardiovascular disease
- type diabetes
- machine learning
- mass spectrometry
- dna methylation
- binding protein
- big data
- hiv testing